Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC) - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2021

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

F. Tantot
  • Fonction : Auteur

Dates et versions

hal-03440342 , version 1 (22-11-2021)

Identifiants

Citer

L. Kinget, E. Roussel, D. Lambrechts, B. Boeckx, A. T. L. Verbiest, et al.. Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC). Annals of Oncology, 2021, 32, pp.S706-S706. ⟨10.1016/j.annonc.2021.08.085⟩. ⟨hal-03440342⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More